Insulin and lipoprotein metabolism with special reference to the diabetic state.
Tomkin
G H
GH
Adelaide Hospital, Dublin, Ireland.
Owens
D
D
D001057:Apolipoproteins E / Q000378:metabolism; D015551:Autoimmunity; D002784:Cholesterol / Q000378:metabolism; D002914:Chylomicrons / Q000378:metabolism; D003920:Diabetes Mellitus / Q000378:metabolism* / Q000503:physiopathology; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D015228:Hypertriglyceridemia / Q000209:etiology / Q000378:metabolism; D007328:Insulin / Q000378:metabolism* / Q000627:therapeutic use; D007333:Insulin Resistance; D008049:Lipase / Q000378:metabolism; D017270:Lipoprotein(a) / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008099:Liver / Q000201:enzymology
D001057:Apolipoproteins E; D002914:Chylomicrons; D007328:Insulin; D017270:Lipoprotein(a); D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D002784:Cholesterol; D008049:Lipase